Kewaunee Scientific Q2 sales up 39.8% to $54.6M; net loss narrows to $0.09/share from $1.11

KEWAUNEE SCIENTIFIC CORP /DE/

2023-Q2 EPS reported -$0.35 revenue$104,687,000

Sales $54.6M (+39.8% YoY); pre-tax earnings $456k vs loss $2.9M; net loss $243k vs $3.1M.
Diluted loss per share $0.09 vs $1.11; EBITDA $1.25M vs ($2.12M).
Domestic segment sales $38.0M (+26.9%); international segment $16.6M (+82.2%).
Backlog $157.8M (up from $139.7M YoY); cash $16.3M (vs $6.9M); no short-term debt.
CEO says improvement despite legacy direct contracts; continuing shift to dealer partners.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

KEWAUNEE SCIENTIFIC CORP /DE/ reported the second quarter ended October 31, 2022 results: revenue $54,564,000, net income a net loss of $243,000, EPS ($0.09) per diluted share.

Period: the second quarter ended October 31, 2022
Revenue: $54,564,000
Net income: a net loss of $243,000
EPS: ($0.09) per diluted share
Result: reported results

Exact text from the filing

Sales during the second quarter of fiscal year 2023 were $54,564,000, an increase of 39.8% compared to sales of $39,031,000 from the prior year second quarter. Pre-tax earnings for the quarter were $456,000 compared to a pre-tax loss of $2,887,000 for the prior year period. Kewaunee recorded a net loss of $243,000 compared to net loss of $3,100,000 for the prior year period.

View on SEC.gov

Browse all earnings releases →

KEWAUNEE SCIENTIFIC CORP /DE/ filing history →

Source: SEC EDGAR

accession 0000055529-22-000020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.